Table 1.
Therapeutic Interventions and medication dose adjustment during the virtual clinic.
| Medication | Frequency | Percentage |
|---|---|---|
| Metformin | ||
| Intervention and dose adjustment (=111) | ||
| No change | 97 | 87.4% |
| Decrease | 3 | 2.7% |
| Increase | 9 | 8.18% |
| Add on | 1 | 1% |
| Stop | 1 | 1% |
| Gliclazide | ||
| Intervention and dose adjustment (=39) | ||
| No change | 29 | 74.4%% |
| Increase | 7 | 17.9% |
| Stop | 3 | 7.7% |
| Liraglutide | ||
| Intervention and dose adjustment (n=17) | ||
| No change | 5 | 29.4% |
| Increase | 9 | 52.9% |
| Add on | 2 | 11.8% |
| Stop | 1 | 5.9% |
| Pioglitazone | ||
| Intervention and dose adjustment (n=3) | ||
| No change | 2 | 66.7% |
| Add on | 1 | 33.3% |
| Vildagliptin | ||
| Intervention and dose adjustment (n=63) | ||
| No change | 47 | 74.6% |
| Increase | 12 | 19 % |
| Add on | 3 | 4.8% |
| Stop | 1 | 0.8% |
| 30% soluble insulin aspart/protamine-crystallized insulin aspart 70% | ||
| Intervention and dose adjustment (n= 18) | ||
| Same | 4 | 22% |
| Increase | 14 | 78 % |
| Insulin NPH/Regular insulin (70/30) | ||
| Intervention and dose adjustment (n=2) | ||
| Increase | 1 | 50 % |
| Add on | 1 | 50 % |
| insulin glargine only | ||
| Intervention and dose adjustment (n=14) | ||
| Increase | 11 | 78.6% |
| Add on | 3 | 21.4% |
| insulin glargine | ||
| Intervention and dose adjustment (n=58) | ||
| No change | 3 | 5.2% |
| Decrease | 2 | 1.5% |
| Increase | 52 | 40% |
| Add on | 1 | 1.7% |
| Aspart insulin | ||
| Intervention and dose adjustment ((n=60) | ||
| No change | 1 | 1.7% |
| Decrease | 3 | 5% |
| Increase | 52 | 86.7% |
| Add on | 3 | 5% |
| Stop | 1 | 1.7% |